We serve Chemical Name:Methyl 3-bromo-4-nitro-1H-indazole-6-carboxylate CAS:885521-03-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Methyl 3-bromo-4-nitro-1H-indazole-6-carboxylate
CAS.NO:885521-03-9
Synonyms:Methyl 3-bromo-4-nitro-1H-indazole-6-carboxylate;3-Bromo-4-nitro-6-indazolecarboxylic acid methyl ester;1H-Indazole-6-carboxylic acid, 3-bromo-4-nitro-, methyl ester
Molecular Formula:C9H6BrN3O4
Molecular Weight:300.066
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:492.0±40.0 °C at 760 mmHg
Density:1.9±0.1 g/cm3
Index of Refraction:1.706
PSA:100.80000
Exact Mass:298.954163
LogP:2.49
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Methyl 3-bromo-4-nitro-1H-indazole-6-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Indazole-6-carboxylic acid, 3-bromo-4-nitro-, methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 3-bromo-4-nitro-1H-indazole-6-carboxylate Use and application,3-Bromo-4-nitro-6-indazolecarboxylic acid methyl ester technical grade,usp/ep/jp grade.
Related News: Immunocompromised people account for roughly 2.7% of U.S. adults including patients who’ve received an organ transplant, living with HIV or have received active or recent treatment for cancer, Oliver said. N-(2-oxo-3-(4-phenylpiperidin-1-yl)propyl)-5-thia-1,2a1-diazaacenaphthylene-4-carboxamide dihydrochloride manufacturers “We were all surprised by the speed at which the oncology market grew in China,” Dunoyer said on the call. “Even if we don’t expect rare disease to grow at the same speed, it is likely that the speed at which the rare disease grows in China is going to be faster than other markets of the world.” cyclohexyl(6-hydroxy-1-(4-(2-(piperidin-1-yl)ethoxy)benzyl)-3,4-dihydroisoquinolin-2(1H)-yl)methanone suppliers Given ICER’s uncertainty regarding efgartigimod’s dosing and long-term benefits, the group said it’s moderately certain the drug can produce a “comparable, small or substantial net health benefit” in that same group of MG patients. 3-(3-iodo-2-fluorophenyl)-1-(2-(trimethylsilyl)-ethoxymethyl)-5-(2-(trimethylsilyl)ethoxymethyloxy)-quinoxalin-2(1H)-one vendor & factory.
